Next Treatment Options After Failing Adderall and Vyvanse for ADHD
For patients who have failed to respond to Adderall (amphetamine and dextroamphetamine) and Vyvanse (lisdexamfetamine), the next treatment option should be a non-stimulant medication such as atomoxetine, alpha-2 agonists like clonidine or guanfacine, or bupropion.
Treatment Algorithm After Stimulant Failure
Non-Stimulant Medication Options
- When first-line stimulant medications (Adderall and Vyvanse) have failed, switching to a non-stimulant medication is the recommended next step 1, 2
- Atomoxetine (Strattera), a selective norepinephrine reuptake inhibitor, is an established alternative medication for ADHD, though it is generally less efficacious than stimulants 2
- Alpha-2 agonists such as clonidine or guanfacine can be considered, particularly if there are comorbid conditions like tics or aggression 1
- Bupropion may be considered as an alternative treatment, especially if there are comorbid mood symptoms 3
Factors to Consider When Selecting the Next Treatment
- Assess for comorbid conditions that might influence medication selection:
- For patients with comorbid tics, alpha-2 agonists like clonidine or guanfacine may be preferable 1, 4
- For patients with comorbid anxiety or OCD symptoms, carefully monitor as stimulants may have worsened these symptoms 4
- For patients with comorbid aggression or conduct disorder, mood stabilizers or alpha-2 agonists may be added to the treatment regimen 1
Combination Therapy Considerations
- If a single non-stimulant medication is insufficient, combination therapy may be considered:
Important Clinical Considerations
Monitoring and Follow-up
- During initial titration of new medications, maintain weekly contact (can be by telephone) 1
- Once stabilized on a new medication, follow-up appointments should occur at least monthly until symptoms are well-controlled 1
- Systematically assess for side effects specific to the chosen medication at each follow-up 1
Common Pitfalls to Avoid
- Avoid assuming that higher doses of stimulants will be effective if standard doses have failed - "If the top recommended dose does not help, more is not necessarily better" 1
- Be cautious about polypharmacy without clear rationale, as some patients may end up on multiple medications without improved outcomes 5
- Don't overlook the possibility that comorbid conditions (anxiety, mood disorders, tics) may be complicating the treatment response 4
Special Populations
- For pregnant or breastfeeding patients who have failed stimulants, bupropion may be a safer alternative with more established safety data in the perinatal period 3
- For patients with cardiovascular concerns who cannot tolerate stimulants, non-stimulant options are particularly important to consider 6
By following this treatment algorithm after stimulant failure, clinicians can systematically work through evidence-based alternatives to optimize ADHD symptom control and minimize side effects.